Manish Assar, MD
Clinical Cardiac Electrophysiology · Dallas, TXNPI 1801863634
Payments from drug & device makers
Across 409 payments — averaging $79.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$12K
- Abbott$9K
- E.r. Squibb & Sons, L.L.C.$7K
- Boston Scientific$2K
- AOP Health US, LLC$430
- Biosense Webster, Inc.$356
- plus $2K from 28 others
What the payments were for
- Speaking & faculty fees$16,31350%
- Travel & lodging$3,71111%
- Food & beverage$12,48038%
- Education$90%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 152 | $12,135 |
| Abbott | 120 | $9,228 |
| E.r. Squibb & Sons, L.L.C. | 11 | $6,524 |
| Boston Scientific | 60 | $2,277 |
| AOP Health US, LLC | 1 | $430 |
| Biosense Webster, Inc. | 10 | $356 |
| Medical Device Business Services, Inc. | 8 | $304 |
| Impulse Dynamics (USA) Inc. | 3 | $216 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 7 | $115 |
| Cardiva Medical, Inc. | 3 | $112 |
| Pfizer | 3 | $108 |
| Biotronik Inc. | 3 | $84 |
| Atricure, Inc. | 2 | $66 |
| Innovation Technologies Inc | 1 | $64 |
| Kestra Medical Technology Services, Inc. | 3 | $55 |
| Johnson & Johnson(2 entities) | 3 | $50 |
| Edwards Lifesciences | 1 | $47 |
| Inspire Medical Systems, Inc. | 1 | $41 |
| Novo Nordisk | 2 | $30 |
| Philips North America LLC | 1 | $29 |
| Stryker | 1 | $25 |
| Sanofi | 1 | $24 |
| Argentum Medical | 1 | $23 |
| Altathera Pharmaceuticals LLC | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $19 |
| Vital Connect, Inc | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $16 |
| Cvrx, Inc. | 1 | $16 |
| Amgen | 1 | $14 |
| Itamar Medical Inc | 1 | $13 |
| Boehringer Ingelheim | 1 | $12 |
| Cook Medical LLC | 1 | $12 |
| Lundbeck LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ELIQUIS$6,350
- ENDURITY$2,588
- Resolute$2,412
- GALLANT$2,343
- AVEIR$888
- Rapiblyk$860
- GENERAL - THERAPIES$484
- Micra$459
- OPTIMIZER$288
- COBALT DR MRI SURESCAN$149
- ONYX FRONTIER$146
- SYMPLICITY G3$137
- Capsure$114
- Carto 3 System$110
- Fortify Assura$109
How this compares
$32,513 in reported general payments places this provider in the 45th percentile of 233 clinical cardiac electrophysiology providers in Texas.
See all clinical cardiac electrophysiology providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 390 | $377,672 |
| XareltoRivaroxaban | 104 | $96,648 |
| MultaqDronedarone Hcl | 40 | $35,552 |
| Flecainide Acetate | 82 | $4,877 |
| Dofetilide | 22 | $3,592 |
| Amiodarone Hcl | 182 | $2,750 |
| Metoprolol Succinate | 98 | $1,761 |
| Propafenone Hcl ErPropafenone Hcl | 12 | $967 |
| Carvedilol | 71 | $515 |
| SotalolSotalol Hcl | 15 | $507 |
| Digoxin | 24 | $465 |
| Potassium Chloride | 26 | $432 |
| Metoprolol Tartrate | 43 | $348 |
| Diltiazem 24hr ErDiltiazem Hcl | 15 | $287 |
| Atorvastatin Calcium | 24 | $250 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $108 | $377,672390 claims |
| Johnson & JohnsonXarelto | $50 | $96,648104 claims |
| Sanofi-aventis U.S. LLCMultaq | $17 | $35,55240 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 233 clinical cardiac electrophysiology providers in Texas.
Other clinical cardiac electrophysiology in Dallas
- Mustafa DohadwalaDallas$814K
- Charles LampeDallas$206K
- Russell CanhamDallas$184K
- Phi WiegnDallas$154K
- Praveen RaoDallas$135K
- Adam ShapiraDallas$135K
- Brian leDallas$115K
- Andrea NataleAustin$7.8M
- George ManoukianShenandoah$3.2M
- Rodney HortonAustin$2.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.